Androgen exposure potentiates formation of intratubular communities and renal abscesses by Escherichia coli

Kidney Int. 2018 Sep;94(3):502-513. doi: 10.1016/j.kint.2018.04.023. Epub 2018 Jul 3.

Abstract

Females across their lifespan and certain male populations are susceptible to urinary tract infections (UTI). The influence of female vs. male sex on UTI is incompletely understood, in part because preclinical modeling has been performed almost exclusively in female mice. Here, we employed established and new mouse models of UTI with uropathogenic Escherichia coli (UPEC) to investigate androgen influence on UTI pathogenesis. Susceptibility to UPEC UTI in both male and female hosts was potentiated with 5α-dihydrotestosterone, while males with androgen receptor deficiency and androgenized females treated with the androgen receptor antagonist enzalutamide were protected from severe pyelonephritis. In androgenized females and in males, UPEC formed dense intratubular, biofilm-like communities, some of which were sheltered from infiltrating leukocytes by the tubular epithelium and by peritubular fibrosis. Abscesses were nucleated by small intratubular collections of UPEC first visualized at five days postinfection and briskly expanded over the subsequent 24 hours. Male mice deficient in Toll-like receptor 4, which fail to contain UPEC within abscesses, were susceptible to lethal dissemination. Thus, androgen receptor activation imparts susceptibility to severe upper-tract UTI in both female and male murine hosts. Visualization of intratubular UPEC communities illuminates early renal abscess pathogenesis and the role of abscess formation in preventing dissemination of infection. Additionally, our study suggests that androgen modulation may represent a novel therapeutic route to combat recalcitrant or recurrent UTI in a range of patient populations.

Keywords: androgen receptor; inflammation; pyelonephritis; testosterone.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Abscess / microbiology
  • Abscess / pathology*
  • Androgen Receptor Antagonists / pharmacology*
  • Androgen Receptor Antagonists / therapeutic use
  • Androgens / pharmacology*
  • Animals
  • Benzamides
  • Dihydrotestosterone / pharmacology
  • Disease Models, Animal
  • Disease Susceptibility / microbiology
  • Disease Susceptibility / pathology
  • Escherichia coli Infections / drug therapy
  • Escherichia coli Infections / microbiology
  • Escherichia coli Infections / pathology
  • Female
  • Humans
  • Kidney Tubules / drug effects
  • Kidney Tubules / microbiology
  • Kidney Tubules / pathology*
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Mice, Transgenic
  • Nitriles
  • Phenylthiohydantoin / analogs & derivatives
  • Phenylthiohydantoin / pharmacology
  • Phenylthiohydantoin / therapeutic use
  • Pyelonephritis / drug therapy
  • Pyelonephritis / microbiology
  • Pyelonephritis / pathology*
  • Receptors, Androgen / metabolism*
  • Sex Factors
  • Toll-Like Receptor 4 / genetics
  • Toll-Like Receptor 4 / metabolism
  • Treatment Outcome
  • Urinary Tract Infections / drug therapy
  • Urinary Tract Infections / microbiology
  • Urinary Tract Infections / pathology
  • Uropathogenic Escherichia coli / pathogenicity

Substances

  • Androgen Receptor Antagonists
  • Androgens
  • Benzamides
  • Nitriles
  • Receptors, Androgen
  • Tlr4 protein, mouse
  • Toll-Like Receptor 4
  • Dihydrotestosterone
  • Phenylthiohydantoin
  • enzalutamide